Mandatory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England: The first 10 years

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 4, 2012, Pages 802-809

  Johnson, Alan P ^a   Davies, John ^a   Guy, Rebecca ^a   Abernethy, Julia ^a   Sheridan, Elizabeth ^a   Pearson, Andrew ^a,b   Duckworth, Georgia ^a,c  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b UNIVERSITY OF MARYLAND   (United States)

^c NONE

Author keywords

Antibiotic resistance; Nosocomial infections; S. aureus

Indexed keywords

ANTIBIOTIC AGENT; METICILLIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BLOOD CULTURE; BLOOD SAMPLING; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL PROTOCOL; COMMUNITY ACQUIRED PNEUMONIA; DEMOGRAPHY; DISEASE SURVEILLANCE; EPIDEMIOLOGICAL DATA; FEEDBACK SYSTEM; GROUPS BY AGE; HAND WASHING; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INCIDENCE; MEDICAL SPECIALIST; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PATHOGENESIS; PREVALENCE; PUBLIC HEALTH; RISK FACTOR; UNITED KINGDOM; WEB BROWSER;

BACTEREMIA; DISEASE NOTIFICATION; ENGLAND; HUMANS; INCIDENCE; INFECTION CONTROL; MANDATORY REPORTING; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS;

EID: 84858635387     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr561     Document Type: Article

References (37)

1. Johnson AP, Pearson A, Duckworth G. Surveillance and epidemiology of MRSA bacteraemia in the UK. J Antimicrob Chemother 2005; 56: 455-62.
2. HANSARD 1803-2005. Written Answers - March 11, 1997. http://hansard.millbanksystems.com/search/mrsa%20nhs?page=4 (28 November 2011, date last accessed).
3. Department of Health. Surveillance of Healthcare Associated Infections, CMO's Update 30. 2001. http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4013652.pdf (29 November 2011, date last accessed).
4. PHLS. First report of the Department of Health's mandatory MRSA bacteraemia surveillance scheme in acute NHS Trusts in England: April to September 2001. CDR Wkly 2002; 12: no. 6, 7 February 2002. http://www.hpa.org.uk/cdr/archives/2002/cdr0602.pdf (28 November 2011, date last accessed).
5. PHLS. The first year of the Department of Health's mandatory MRSA bacteraemia surveillance scheme in acute NHS Trusts in England: April 2001-March 2002. CDR Wkly 2002; 12: no. 25, 20 June 2002. http://www.hpa.org.uk/cdr/archives/2002/cdr2502.pdf (28 November 2011, date last accessed).
6. HPA. The second year of the Department of Health's mandatory MRSA bacteraemia surveillance scheme in acute NHS Trusts in England: April 2002-March 2003. CDR Wkly 2003; 13: no. 25, 19 June 2003. http://www.hpa.org.uk/cdr/archives/2003/cdr2503.pdf (28 November 2011, date last accessed).
7. HPA. The third year of regional and national analyses of the Department of Health's mandatory MRSA surveillance scheme in England: April 2001-March 2004. CDR Wkly 2004; 14: no. 29, 15 July 2004. http://www.hpa.org.uk/cdr/archives/2004/cdr2904.pdf (28 November 2011, date last accessed).
8. HPA. The fourth year of regional and national analyses of the Department of Health's mandatory Staphylococcus aureus surveillance scheme in England: April 2001-March 2005. CDR Wkly 2005; 15: no. 25, 23 June 2005. http://www.hpa.org.uk/cdr/archives/2005/cdr2505.pdf (28 November 2011, date last accessed).
9. Department of Health. Hospital Activity Team. Guidance/Definitions: KH03 http://www.performance.doh.gov.uk/hospitalactivity/nhsweb/kh03fq.htm (28 November 2011, date last accessed).
10. Safdar N, Bradley EA. The risk of infection after nasal colonization with Staphylococcus aureus. Am J Med 2008; 121: 310-5.
11. Department of Health. NHS to Track Wider Range of Infections. 2010. http://www.dh.gov.uk/en/MediaCentre/Pressreleases/DH_120208 (28 November 2011, date last accessed).
12. Department of Health. Extension of Mandatory Surveillance to Meticillin Sensitive Staphylococcus aureus (MSSA) and Updated Healthcare Associated Infections Clinical Guidance (HCAI Compendium). 2011. http://www.dh.gov.uk/en/Publicationsandstatistics/Lettersandcirculars/Dearcolleagueletters/DH_123275 (28 November 2011, date last accessed).
13. HPA. Quarterly Epidemiological Commentary: Mandatory MRSA Bacteraemia and Clostridium difficile Infection (up to July-September 2010). http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1296682346613 (28 November 2011, date last accessed).
14. HPA. Mandatory Surveillance of Staphylococcus aureus Bacteraemia. 2011. http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/HPAweb_C/1233906818165 (28 November 2011, date last accessed).
15. UK Statistics Authority. Code of Practice for Official Statistics. 2009. http://www.statisticsauthority.gov.uk/assessment/code-of-practice/index.html (28 November 2011, date last accessed).
16. HPA. Mandatory Surveillance Weekly Reports. http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/HPAweb_C/1274089052145 (28 November 2011, date last accessed).
17. HM Government. NHS Weekly MRSA Data Set. http://data.gov.uk/dataset/nhs-meticillin-resistant-staphylococcus-aureus-bacteraemiadataset-weekly (28 November 2011, date last accessed).
18. HPA. Quarterly Epidemiological Commentary: Mandatory MRSA Bacteraemia and Clostridium difficile Infection (up to April-June 2010). http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/StaphylococcusAureus/EpidemiologicalData/MandatorySurveillance/HCAIQuarterlyEpidemiology/ (28 November 2011, date last accessed).
19. HPA. Quarterly Epidemiological Commentary: Mandatory MRSA Bacteraemia and Clostridium difficile Infection (up to October-December 2010). http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/StaphylococcusAureus/EpidemiologicalData/MandatorySurveillance/HCAIQuarterlyEpidemiology/ (28 November 2011, date last accessed).
20. HPA. Quarterly Epidemiological Commentary: Mandatory MRSA Bacteraemia, Clostridium difficile Infection and MSSA Bacteraemia (up to January-March 2011). http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/StaphylococcusAureus/EpidemiologicalData/MandatorySurveillance/HCAIQuarterlyEpidemiology/ (28 November 2011, date last accessed).
21. HPA. Health Secretary announces MRSA target. CDR Wkly 2004; 14: no. 46, 11 November 2004. http://www.hpa.org.uk/cdr/archives/2004/cdr4604.pdf (28 November 2011, date last accessed).
22. Department of Health. Reporting MRSA Data: Overview of Arrangements. 2006. http://www.dh.gov.uk/en/Publicationsandstatistics/Lettersandcirculars/Professionalletters/Chiefmedicalofficerletters/DH_4132578 (28 November 2011, date last accessed).
23. BBC News. MRSA Target 'Likely to be Missed'. 2007. http://news.bbc.co.uk/1/hi/6249149.stm (28 November 2011, date last accessed).
24. Pearson A, Chronias A, Murray M. Voluntary and mandatory surveillance for methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) bacteraemia in England. J Antimicrob Chemother 2009; 64 Suppl 1: i11-7.
25. Stone S, Slade R, Fuller C et al. Early communication: does a national campaign to improve hand hygiene in the NHS work? Initial English and Welsh experience from the NOSEC study (National Observational Study to Evaluate the CleanYourHandsCampaign). J Hosp Infect 2007; 66: 293-6.
26. Enoch DA, Cargill JS, Sismey A et al. MRSA surveillance in a UK district hospital: measuring clinical isolates with MRSA is more useful than measuring MRSA bacteraemias. J Hosp Infect 2011; 79: 287-91.
27. Department of Health. Saving Lives: Reducing Infection, Delivering Clean and Safe Care. 2007. http://webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_078134 (28 November 2011, date last accessed).
28. Edgeworth JD. Has decolonization played a central role in the decline in UK methicillin-resistant Staphylococcus aureus transmission? A focus on evidence from intensive care. J Antimicrob Chemother 2011; 66 Suppl 2: 41-7.
29. Wyllie D, Paul J, Crook D. Waves of trouble: MRSA strain dynamics and assessment of the impact of infection control. J Antimicrob Chemother 2011; 66: 2685-8.
30. HPA. Results From the Mandatory Surveillance of MRSA Bacteraemia, Acute Trust Counts and Rates by Quarter and Financial Year (FY) - April 2007 Onwards. http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/HPAweb_C/1233906819629 (29 November 2011, date last accessed).
31. HPA. Surveillance of Healthcare Associated Infections Report: 2008. http://www.hpa.org.uk/Publications/InfectiousDiseases/AntimicrobialAndHealthcareAssociatedInfections/0807HCAIAnnualReport2008/ (29 November 2011, date last accessed).
32. HPA. Quarterly Epidemiological Commentary: Mandatory MRSA Bacteraemia and Clostridium difficile Infection (up to January-March 2010). http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/HPAweb_C/1259151891722 (30 November 2011, date last accessed).
33. Wilson J, Guy R, Elgohari S et al. Trends in sources of meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia: data from the national mandatory surveillance of MRSA bacteraemia in England, 2006-2009. J Hosp Infect 2011; 79: 211-7.
34. NHS Information Centre. Hospital Episode Statistics. http://www.hesonline.nhs.uk/Ease/servlet/ContentServer?siteID=1937 (29 November 2011, date last accessed).
35. Tenover FC, Goering RV. Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology. J Antimicrob Chemother 2009; 64: 441-6.
36. Coia JE, Duckworth GJ, Edwards DI et al. Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect 2006; 63 Suppl 1: S1-44.
37. Mumtaz S, Bishop LA, Wright AL et al. Burden of meticillin-resistant Staphylococcus aureus colonization and infection in London acute hospitals: retrospective on a voluntary surveillance programme. J Hosp Infect 2011; 79: 309-12.